التفاصيل البيبلوغرافية
| العنوان: |
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. |
| المؤلفون: |
Sherr, Jennifer L.1 jennifer.sherr@yale.edu, Tauschmann, Martin2,3, Battelino, Tadej4,5, de Bock, Martin6, Forlenza, Gregory7, Roman, Rossana8, Hood, Korey K.9, Maahs, David M.10 |
| المصدر: |
Pediatric Diabetes. Oct2018 Supplement S27, Vol. 19, p302-325. 24p. 4 Charts. |
| مصطلحات موضوعية: |
*DIAGNOSIS of diabetes, *INSULIN therapy, *AGE distribution, *BIOSENSORS, *BLOOD sugar monitoring, *DECISION support systems, *DRUG delivery systems, *DRUG infusion pumps, *HYPERTROPHY, *HYPOGLYCEMIA, *INFORMATION storage & retrieval systems, *MEDICAL databases, *INSULIN pumps, *MEDICAL protocols, *MEDICAL practice, *PATIENT satisfaction, *PROFESSIONAL associations, *QUALITY of life, *TELEMEDICINE, *TERMINATION of treatment, *TREATMENT effectiveness, *SEVERITY of illness index, *DISEASE duration, *MOBILE apps, *GLYCEMIC control |
| مستخلص: |
The article focuses on the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines on diabetes technologies. It mentions that real-time continuous glucose monitors (CGM) can be used effectively for lowering hemoglobin A1c (HbA1c). It highlights effectiveness of sensor augmented pump (SAP) therapy in children and adolescents over multiple daily injection (MDI) with self-monitoring of blood glucose (SMBG) in reduction of HbA1c. |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder